COLL logo

Collegium Pharmaceutical, Inc. (COLL) Selling, General & Administrative Expenses

Annual SG&A:

$210.36M+$51.16M(+32.13%)
December 31, 2024

Summary

  • As of today, COLL annual SG&A is $210.36 million, with the most recent change of +$51.16 million (+32.13%) on December 31, 2024.
  • During the last 3 years, COLL annual SG&A has risen by +$91.40 million (+76.84%).
  • COLL annual SG&A is now at all-time high.

Performance

COLL SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLincome statement metrics

Quarterly SG&A:

$73.64M-$2.79M(-3.65%)
June 1, 2025

Summary

  • As of today, COLL quarterly SG&A is $73.64 million, with the most recent change of -$2.79 million (-3.65%) on June 1, 2025.
  • Over the past year, COLL quarterly SG&A has increased by +$30.30 million (+69.93%).
  • COLL quarterly SG&A is now -3.65% below its all-time high of $76.42 million, reached on March 31, 2025.

Performance

COLL Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLincome statement metrics

TTM SG&A:

-$651.72M+$36.27M(+5.27%)
June 1, 2025

Summary

  • As of today, COLL TTM SG&A is -$651.72 million, with the most recent change of +$36.27 million (+5.27%) on June 1, 2025.
  • Over the past year, COLL TTM SG&A has dropped by -$805.27 million (-524.41%).
  • COLL TTM SG&A is now -540.49% below its all-time high of -$101.75 million.

Performance

COLL TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

COLL Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+32.1%+69.9%-524.4%
3Y3 Years+76.8%+78.5%-526.2%
5Y5 Years+80.7%+151.1%-681.4%

COLL Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+76.8%-3.6%+123.5%at high+42.8%
5Y5-Yearat high+84.8%-3.6%+178.7%at high+53.8%
All-TimeAll-Timeat high>+9999.0%-3.6%>+9999.0%-540.5%+54.4%

COLL Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$73.64M(-3.6%)
$275.11M(+12.4%)
Mar 2025
-
$76.42M(+21.1%)
$244.80M(+16.4%)
Dec 2024
$210.36M(+32.1%)
$63.09M(+1.8%)
$210.36M(+16.7%)
Sep 2024
-
$61.95M(+43.0%)
$180.21M(+17.4%)
Jun 2024
-
$43.34M(+3.2%)
$153.56M(+3.5%)
Mar 2024
-
$41.98M(+27.4%)
$148.41M(-6.8%)
Dec 2023
$159.21M(-7.5%)
$32.94M(-6.7%)
$159.21M(-3.1%)
Sep 2023
-
$35.30M(-7.6%)
$164.30M(-1.8%)
Jun 2023
-
$38.19M(-27.6%)
$167.37M(-1.8%)
Mar 2023
-
$52.77M(+38.8%)
$170.43M(-1.0%)
Dec 2022
$172.19M(+44.7%)
$38.03M(-0.9%)
$172.19M(+7.1%)
Sep 2022
-
$38.37M(-7.0%)
$160.76M(+5.1%)
Jun 2022
-
$41.25M(-24.3%)
$152.90M(+7.7%)
Mar 2022
-
$54.53M(+105.0%)
$142.01M(+19.4%)
Dec 2021
$118.96M(+4.5%)
$26.60M(-12.8%)
$118.96M(-0.2%)
Sep 2021
-
$30.51M(+0.5%)
$119.18M(+3.6%)
Jun 2021
-
$30.37M(-3.5%)
$115.09M(+0.9%)
Mar 2021
-
$31.48M(+17.3%)
$114.05M(+0.2%)
Dec 2020
$113.83M(-2.2%)
$26.82M(+1.5%)
$113.83M(+1.5%)
Sep 2020
-
$26.43M(-9.9%)
$112.10M(-3.2%)
Jun 2020
-
$29.32M(-6.2%)
$115.74M(+0.3%)
Mar 2020
-
$31.26M(+24.6%)
$115.36M(-0.9%)
Dec 2019
$116.45M
$25.09M(-16.6%)
$116.45M(-4.4%)
DateAnnualQuarterlyTTM
Sep 2019
-
$30.07M(+3.9%)
$121.81M(-2.7%)
Jun 2019
-
$28.93M(-10.6%)
$125.19M(-1.8%)
Mar 2019
-
$32.35M(+6.2%)
$127.53M(+0.6%)
Dec 2018
$126.76M(+36.7%)
$30.45M(-9.0%)
$126.76M(+4.4%)
Sep 2018
-
$33.45M(+6.9%)
$121.40M(+9.7%)
Jun 2018
-
$31.28M(-1.0%)
$110.71M(+9.1%)
Mar 2018
-
$31.58M(+25.9%)
$101.49M(+9.4%)
Dec 2017
$92.76M(+15.0%)
$25.09M(+10.2%)
$92.76M(-0.3%)
Sep 2017
-
$22.76M(+3.2%)
$93.03M(-0.9%)
Jun 2017
-
$22.06M(-3.4%)
$93.84M(+2.1%)
Mar 2017
-
$22.85M(-9.9%)
$91.95M(+14.0%)
Dec 2016
$80.63M(+325.9%)
$25.37M(+7.6%)
$80.63M(+27.6%)
Sep 2016
-
$23.57M(+16.8%)
$63.17M(+38.8%)
Jun 2016
-
$20.17M(+75.0%)
$45.51M(+61.0%)
Mar 2016
-
$11.53M(+45.8%)
$28.27M(+49.3%)
Dec 2015
$18.93M(+599.6%)
$7.91M(+33.8%)
$18.93M(+57.2%)
Sep 2015
-
$5.91M(+101.3%)
$12.05M(+76.5%)
Jun 2015
-
$2.93M(+34.3%)
$6.83M(+54.6%)
Mar 2015
-
$2.19M(+114.2%)
$4.42M(+63.2%)
Dec 2014
$2.71M(+43.6%)
$1.02M(+48.5%)
$2.71M(+60.5%)
Sep 2014
-
$687.00K(+31.4%)
$1.69M(+68.8%)
Jun 2014
-
$523.00K(+10.1%)
$998.00K(+110.1%)
Mar 2014
-
$475.00K
$475.00K
Dec 2013
$1.89M
-
-

FAQ

  • What is Collegium Pharmaceutical, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. annual SG&A year-on-year change?
  • What is Collegium Pharmaceutical, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. quarterly SG&A year-on-year change?
  • What is Collegium Pharmaceutical, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. TTM SG&A year-on-year change?

What is Collegium Pharmaceutical, Inc. annual SG&A?

The current annual SG&A of COLL is $210.36M

What is the all-time high annual SG&A for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high annual SG&A is $210.36M

What is Collegium Pharmaceutical, Inc. annual SG&A year-on-year change?

Over the past year, COLL annual SG&A has changed by +$51.16M (+32.13%)

What is Collegium Pharmaceutical, Inc. quarterly SG&A?

The current quarterly SG&A of COLL is $73.64M

What is the all-time high quarterly SG&A for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high quarterly SG&A is $76.42M

What is Collegium Pharmaceutical, Inc. quarterly SG&A year-on-year change?

Over the past year, COLL quarterly SG&A has changed by +$30.30M (+69.93%)

What is Collegium Pharmaceutical, Inc. TTM SG&A?

The current TTM SG&A of COLL is -$651.72M

What is the all-time high TTM SG&A for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high TTM SG&A is -$101.75M

What is Collegium Pharmaceutical, Inc. TTM SG&A year-on-year change?

Over the past year, COLL TTM SG&A has changed by -$805.27M (-524.41%)
On this page